Frost & Sullivan Release: Underdeveloped Segments Hold Immense Potential for Growth in the U.S. Neurostimulation Market

PALO ALTO, Calif.--(BUSINESS WIRE)--In spite of numerous challenges, neurostimulators have developed rapidly due to their acknowledged clinical efficacy and positive patient response. With an increasing aging population and dissatisfaction with current therapies, the demand for alternative treatments represents the greatest driver for the growth of neurostimulation. Ultimately, manufacturers that pay top dollar for compelling research and quality development will reap the rewards of a market poised to become a multi-billion dollar market by 2013.